Asparaginase-associated pancreatitis in children

British Journal of Haematology

Volumn 159, Issue 1, 2012, Pages 18-27

  Raja, Raheel Altaf ^a   Schmiegelow, Kjeld ^a,b   Frandsen, Thomas Leth ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Asparaginase; Leukaemia; Pancreatitis; Risk factors; Toxicity

Indexed keywords

AMYLASE; ASPARAGINASE; OCTREOTIDE; PROTEINASE INHIBITOR; TRIACYLGLYCEROL LIPASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE HEMORRHAGIC PANCREATITIS; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANAPHYLAXIS; ANTINEOPLASTIC ACTIVITY; BLEEDING; CANCER SURVIVAL; CFTR GENE; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; CTRC GENE; DISEASE CLASSIFICATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG WITHDRAWAL; ECHOGRAPHY; EPIGASTRIC PAIN; EVENT FREE SURVIVAL; FEVER; FLUID RESUSCITATION; GENE; GENETIC PREDISPOSITION; HUMAN; HYPERLIPIDEMIA; HYPOTENSION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIVER TOXICITY; MULTIPLE CYCLE TREATMENT; NAUSEA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS PSEUDOCYST; PATHOPHYSIOLOGY; PLEURA EFFUSION; PRIORITY JOURNAL; PRSS1 GENE; PRSS2 GENE; REVIEW; RISK ASSESSMENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA; THROMBOSIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING;

ASPARAGINASE; HUMANS; PANCREATITIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; TREATMENT OUTCOME;

EID: 84866311433     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12016     Document Type: Review

References (92)

1. Albertsen, B.K., Hasle, H., Clausen, N., Schroder, H. & Jakobsen, P. (2005) Pain intensity and bioavailability of intramuscular asparaginase and a local anesthetic: a double-blinded study. Pediatric Blood and Cancer, 44, 255-258.
2. Alvarez, O.A. & Zimmerman, G. (2000) Pegaspargase-induced pancreatitis. Medical and Pediatric Oncology, 34, 200-205.
3. Andersen, J., Heilmann, C., Jacobsen, N., Bendtzen, K. & Muller, K. (2005) Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation. International Immunopharmacology, 5, 67-71.
4. Appel, I.M., Hop, W.C., van Kessel-Bakvis, C., Stigter, R. & Pieters, R. (2008) l-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thrombosis and Haemostasis, 100, 330-337.
5. Asselin, B.L., Whitin, J.C., Coppola, D.J., Rupp, I.P., Sallan, S.E. & Cohen, H.J. (1993) Comparative pharmacokinetic studies of three asparaginase preparations. Journal of Clinical Oncology, 11, 1780-1786.
6. Avramis, V.I. & Panosyan, E.H. (2005) Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clinical Pharmacokinetics, 44, 367-393.
7. Avramis, V.I., Sencer, S., Periclou, A.P., Sather, H., Bostrom, B.C., Cohen, L.J., Ettinger, A.G., Ettinger, L.J., Franklin, J., Gaynon, P.S., Hilden, J.M., Lange, B., Majlessipour, F., Mathew, P., Needle, M., Neglia, J., Reaman, G., Holcenberg, J.S. & Stork, L. (2002) A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood, 99, 1986-1994.
8. Bai, H.X., Lowe, M.E. & Husain, S.Z. (2011) What have we learned about acute pancreatitis in children? Journal of Pediatric Gastroenterology and Nutrition, 52, 262-270.
9. Baillie, J. (2007) AGA Institute medical position statement on acute pancreatitis. Gastroenterology, 132, 2019-2021.
10. Banks, P.A. & Freeman, M.L. (2006) Practice guidelines in acute pancreatitis. The American Journal of Gastroenterology, 101, 2379-2400.
11. Bassi, C., Larvin, M. & Villatoro, E. (2003) Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database of Systematic Reviews, CD002941.
12. van den Berg, H. (2011) Asparaginase revisited. Leukemia and Lymphoma, 52, 168-178.
13. Berney, T., Belli, D., Bugmann, P., Beghetti, M., Morel, P. & LeCoultre, C. (1996) Influence of severe underlying pathology and hypovolemic shock on the development of acute pancreatitis in children. Journal of Pediatric Surgery, 31, 1256-1261.
14. Bradley, III, E.L. (1993) A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Archives of Surgery, 128, 586-590.
15. Chang, Y.T., Chang, M.C., Su, T.C., Liang, P.C., Su, Y.N., Kuo, C.H., Wei, S.C. & Wong, J.M. (2008) Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clinical Chemistry, 54, 131-138.
16. Cheruvu, C.V., Clarke, M.G., Prentice, M. & Eyre-Brook, I.A. (2003) Conservative treatment as an option in the management of pancreatic pseudocyst. Annals of the Royal College of Surgeons of England, 85, 313-316.
17. Cohen, H., Bielorai, B., Harats, D., Toren, A. & Pinhas-Hamiel, O. (2010) Conservative treatment of l-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer, 54, 703-706.
18. Davidsen, M.L., Dalhoff, K. & Schmiegelow, K. (2008) Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 30, 831-849.
19. Dellinger, E.P., Tellado, J.M., Soto, N.E., Ashley, S.W., Barie, P.S., Dugernier, T., Imrie, C.W., Johnson, C.D., Knaebel, H.P., Laterre, P.F., Maravi-Poma, E., Kissler, J.J., Sanchez-Garcia, M. & Utzolino, S. (2007) Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Annals of Surgery, 245, 674-683.
20. Dietel, V., Buhrdel, P., Hirsch, W., Korholz, D. & Kiess, W. (2007) Cerebral sinus occlusion in a boy presenting with asparaginase-induced hypertriglyceridemia. Klinische Pädiatrie, 219, 95-96.
21. Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., Benoit, Y., Robert, A., Manel, A.M., Vilmer, E., Otten, J. & Philippe, N. (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood, 99, 2734-2739.
22. Flores-Calderon, J., Exiga-Gonzalez, E., Moran-Villota, S., Martin-Trejo, J. & Yamamoto-Nagano, A. (2009) Acute pancreatitis in children with acute lymphoblastic leukemia treated with l-asparaginase. Journal of Pediatric Hematology/Oncology, 31, 790-793.
23. Garcia-Barrasa, A., Borobia, F.G., Pallares, R., Jorba, R., Poves, I., Busquets, J. & Fabregat, J. (2009) A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. Journal of Gastrointestinal Surgery, 13, 768-774.
24. Gardner, T.B., Vege, S.S., Chari, S.T., Petersen, B.T., Topazian, M.D., Clain, J.E., Pearson, R.K., Levy, M.J. & Sarr, M.G. (2009) Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology, 9, 770-776.
25. Garrington, T., Bensard, D., Ingram, J.D. & Silliman, C.C. (1998) Successful management with octreotide of a child with l-asparaginase induced hemorrhagic pancreatitis. Medical and Pediatric Oncology, 30, 106-109.
26. Gorelick, F.S. & Thrower, E. (2009) The acinar cell and early pancreatitis responses. Clinical Gastroenterology and Hepatology, 7, S10-S14.
27. Gorry, M.C., Gabbaizedeh, D., Furey, W., Gates, Jr, L.K., Preston, R.A., Aston, C.E., Zhang, Y., Ulrich, C., Ehrlich, G.D. & Whitcomb, D.C. (1997) Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology, 113, 1063-1068.
28. Gumaste, V.V. & Aron, J. (2010) Pseudocyst management: endoscopic drainage and other emerging techniques. Journal of Clinical Gastroenterology, 44, 326-331.
29. Habashi, S. & Draganov, P.V. (2009) Pancreatic pseudocyst. World Journal of Gastroenterology, 15, 38-47.
30. Haddock, G., Coupar, G., Youngson, G.G., MacKinlay, G.A. & Raine, P.A. (1994) Acute pancreatitis in children: a 15-year review. Journal of Pediatric Surgery, 29, 719-722.
31. Hatzipantelis, E., Pana, Z.D., Pavlou, E., Balakou, E., Tsotoulidou, V., Papageorgiou, T., Tragiannidis, A. & Athanassiadou, F. (2011) Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and l-asparaginase associated pancreatitis: a possible drug interaction. Klinische Pädiatrie, 223, 360-363.
32. Heider, R., Meyer, A.A., Galanko, J.A. & Behrns, K.E. (1999) Percutaneous drainage of pancreatic pseudocysts is associated with a higher failure rate than surgical treatment in unselected patients. Annals of Surgery, 229, 781-787.
33. Hjalgrim, L.L., Rostgaard, K., Hjalgrim, H., Westergaard, T., Thomassen, H., Forestier, E., Gustafsson, G., Kristinsson, J., Melbye, M. & Schmiegelow, K. (2004) Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. Journal of the National Cancer Institute, 96, 1549-1556.
34. Isenmann, R., Runzi, M., Kron, M., Kahl, S., Kraus, D., Jung, N., Maier, L., Malfertheiner, P., Goebell, H. & Beger, H.G. (2004) Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology, 126, 997-1004.
35. Iwamoto, S., Mihara, K., Downing, J.R., Pui, C.H. & Campana, D. (2007) Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. The Journal of Clinical Investigation, 117, 1049-1057.
36. Jaffe, N., Traggis, D., Das, L., Moloney, W.C., Hann, H.W., Kim, B.S. & Nair, R. (1971) l-Asparaginase in the treatment of neoplastic diseases in children. Cancer Research, 31, 942-949.
37. Jazrawi, S.F., Barth, B.A. & Sreenarasimhaiah, J. (2011) Efficacy of endoscopic ultrasound-guided drainage of pancreatic pseudocysts in a pediatric population. Digestive Diseases and Sciences, 56, 902-908.
38. Kearney, S.L., Dahlberg, S.E., Levy, D.E., Voss, S.D., Sallan, S.E. & Silverman, L.B. (2009) Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatric Blood and Cancer, 53, 162-167.
39. Kfoury-Baz, E.M., Nassar, R.A., Tanios, R.F., Otrock, Z.K., Youssef, A.M., Albany, C., Bazarbachi, A. & Salem, Z.M. (2008) Plasmapheresis in asparaginase-induced hypertriglyceridemia. Transfusion, 48, 1227-1230.
40. Knoderer, H.M., Robarge, J. & Flockhart, D.A. (2007) Predicting asparaginase-associated pancreatitis. Pediatric Blood and Cancer, 49, 634-639.
41. Kurre, H.A., Ettinger, A.G., Veenstra, D.L., Gaynon, P.S., Franklin, J., Sencer, S.F., Reaman, G.H., Lange, B.J. & Holcenberg, J.S. (2002) A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli l-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962). Journal of Pediatric Hematology/Oncology, 24, 175-181.
42. Liu, C., Kawedia, J.D., Cheng, C., Pei, D., Fernandez, C.A., Cai, X., Crews, K.R., Kaste, S.C., Panetta, J.C., Bowman, W.P., Jeha, S., Sandlund, J.T., Evans, W.E., Pui, C.H. & Relling, M.V. (2012) Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia, Epub ahead of print. doi: 10.1038/leu.2012.102.
43. Lund, B., Asberg, A., Heyman, M., Kanerva, J., Harila-Saari, A., Hasle, H., Soderhall, S., Jonsson, O.G., Lydersen, S. & Schmiegelow, K. (2011) Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatric Blood and Cancer, 56, 551-559.
44. Malmstrom, M.L., Hansen, M.B., Andersen, A.M., Ersboll, A.K., Nielsen, O.H., Jorgensen, L.N. & Novovic, S. (2012) Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas, 41, 271-277.
45. Morimoto, A., Imamura, T., Ishii, R., Nakabayashi, Y., Nakatani, T., Sakagami, J. & Yamagami, T. (2008) Successful management of severe l-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic. Cancer, 113, 1362-1369.
46. Muller, H.J. & Boos, J. (1998) Use of l-asparaginase in childhood ALL. Critical Reviews in Oncology/Hematology, 28, 97-113.
47. Offman, M.N., Krol, M., Patel, N., Krishnan, S., Liu, J., Saha, V. & Bates, P.A. (2011) Rational engineering of l-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood, 117, 1614-1621.
48. Pandol, S.J. (2006) Acute pancreatitis. Current Opinion in Gastroenterology, 22, 481-486.
49. Parsons, S.K., Skapek, S.X., Neufeld, E.J., Kuhlman, C., Young, M.L., Donnelly, M., Brunzell, J.D., Otvos, J.D., Sallan, S.E. & Rifai, N. (1997) Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood, 89, 1886-1895.
50. Pastor, C.M., Matthay, M.A. & Frossard, J.L. (2003) Pancreatitis-associated acute lung injury: new insights. Chest, 124, 2341-2351.
51. Patel, N., Krishnan, S., Offman, M.N., Krol, M., Moss, C.X., Leighton, C., van Delft, F.W., Holland, M., Liu, J., Alexander, S., Dempsey, C., Ariffin, H., Essink, M., Eden, T.O., Watts, C., Bates, P.A. & Saha, V. (2009) A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug l-asparaginase. The Journal of Clinical Investigation, 119, 1964-1973.
52. Pattillo, J.C. & Funke, R. (2012) Laparoscopic pancreatic necrosectomy in a child with severe acute pancreatitis. Journal of Laparoendoscopic and Advanced Surgical Techniques. Part A, 22, 123-126.
53. Petrov, M.S., Kukosh, M.V. & Emelyanov, N.V. (2006) A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition. Digestive Surgery, 23, 336-344.
54. Piascik, M., Rydzewska, G., Milewski, J., Olszewski, S., Furmanek, M., Walecki, J. & Gabryelewicz, A. (2010) The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study. Pancreas, 39, 863-867.
55. Raetz, E.A. & Salzer, W.L. (2010) Tolerability and efficacy of l-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 32, 554-563.
56. Ridola, V., Buonuomo, P.S., Maurizi, P., Putzulu, R., Annunziata, M.L., Pietrini, D. & Riccardi, R. (2008) Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatric Blood and Cancer, 50, 378-380.
57. Rosendahl, J., Witt, H., Szmola, R., Bhatia, E., Ozsvari, B., Landt, O., Schulz, H.U., Gress, T.M., Pfutzer, R., Lohr, M., Kovacs, P., Bluher, M., Stumvoll, M., Choudhuri, G., Hegyi, P., te Morsche, R.H., Drenth, J.P., Truninger, K., Macek, Jr, M., Puhl, G., Witt, U., Schmidt, H., Buning, C., Ockenga, J., Kage, A., Groneberg, D.A., Nickel, R., Berg, T., Wiedenmann, B., Bodeker, H., Keim, V., Mossner, J., Teich, N. & Sahin-Toth, M. (2008) Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nature Genetics, 40, 78-82.
58. Salvador, C., Meister, B., Crazzolara, R. & Kropshofer, G. (2012) Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and l-asparaginase during induction chemotherapy. Pediatric Blood and Cancer. Epub ahead of print. doi: 10.1002/pbc.24202.
59. Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Soderhall, S. & Taskinen, M. (2010) Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia, 24, 345-354.
60. Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J. & Sallan, S.E. (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood, 97, 1211-1218.
61. Silverman, L.B., Supko, J.G., Stevenson, K.E., Woodward, C., Vrooman, L.M., Neuberg, D.S., Asselin, B.L., Athale, U.H., Clavell, L., Cole, P.D., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M., Schwartz, C.L., O'Brien, J.E., Cohen, H.J. & Sallan, S.E. (2010) Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood, 115, 1351-1353.
62. Solano-Paez, P., Villegas, J.A., Colomer, I., Gutierrez, M.D. & Fernandez-Teijeiro, A. (2011) l-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 33, e122-e124.
63. Solomon, S., Whitcomb, D.C. & LaRusch, J. (1993) PRSS1-related hereditary pancreatitis. In: Source GeneReviews™ [Internet] (ed. by R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens & M.P. Adam), University of Washington, Seattle, WA.
64. Spiegel, R.J., Echelberger, C.K. & Poplack, D.G. (1980) Delayed allergic reactions following intramuscular l-asparaginase. Medical and Pediatric Oncology, 8, 123-125.
65. Stock, W., Douer, D., Deangelo, D.J., Arellano, M., Advani, A., Damon, L., Kovacsovics, T., Litzow, M., Rytting, M., Borthakur, G. & Bleyer, A. (2011) Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leukemia and Lymphoma, 52, 2237-2253.
66. Suzuki, M., Shimizu, T., Kudo, T., Shoji, H., Ohtsuka, Y. & Yamashiro, Y. (2008) Octreotide prevents l-asparaginase-induced pancreatic injury in rats. Experimental Hematology, 36, 172-180.
67. Takeda, K., Matsuno, S., Sunamura, M. & Kakugawa, Y. (1996) Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. American Journal of Surgery, 171, 394-398.
68. Takeda, K., Matsuno, S., Ogawa, M., Watanabe, S. & Atomi, Y. (2001) Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. Journal of Hepato-Biliary-Pancreatic Surgery, 8, 216-220.
69. Takeda, K., Mikami, Y., Fukuyama, S., Egawa, S., Sunamura, M., Ishibashi, T., Sato, A., Masamune, A. & Matsuno, S. (2005) Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas, 30, 40-49.
70. Thoeni, R.F. (2012) The revised Atlanta classification of acute pancreatitis: its importance for the radiologist and its effect on treatment. Radiology, 262, 751-764.
71. Tipnis, N.A., Dua, K.S. & Werlin, S.L. (2008) A retrospective assessment of magnetic resonance cholangiopancreatography in children. Journal of Pediatric Gastroenterology and Nutrition, 46, 59-64.
72. Tokimasa, S. & Yamato, K. (2011) Does octreotide prevent l-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia? British Journal of Haematology, 157, 381-382.
73. Tong, W.H., Pieters, R. & van der Sluis, I.M. (2012) Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase. Pediatric Blood and Cancer, 58, 317-318.
74. Top, P.C., Tissing, W.J., Kuiper, J.W., Pieters, R. & van Eijck, C.H. (2005) l-Asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Pediatric Blood and Cancer, 44, 95-97.
75. Treepongkaruna, S., Thongpak, N., Pakakasama, S., Pienvichit, P., Sirachainan, N. & Hongeng, S. (2009) Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. Journal of Pediatric Hematology/Oncology, 31, 812-815.
76. Vrooman, L.M., Supko, J.G., Neuberg, D.S., Asselin, B.L., Athale, U.H., Clavell, L., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2010) Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer, 54, 199-205.
77. Warshaw, A.L., Bellini, C.A. & Lesser, P.B. (1975) Inhibition of serum and urine amylase activity in pancreatitis with hyperlipemia. Annals of Surgery, 182, 72-75.
78. Weizman, Z. & Durie, P.R. (1988) Acute pancreatitis in childhood. The Journal of Pediatrics, 113, 24-29.
79. Werlin, S.L., Kugathasan, S. & Frautschy, B.C. (2003) Pancreatitis in children. Journal of Pediatric Gastroenterology and Nutrition, 37, 591-595.
80. Whitcomb, D.C. (2010) Genetic aspects of pancreatitis. Annual Review of Medicine, 61, 413-424.
81. Whitcomb, D.C., Gorry, M.C., Preston, R.A., Furey, W., Sossenheimer, M.J., Ulrich, C.D., Martin, S.P., Gates, Jr, L.K., Amann, S.T., Toskes, P.P., Liddle, R., McGrath, K., Uomo, G., Post, J.C. & Ehrlich, G.D. (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genetics, 14, 141-145.
82. Willer, A., Gerss, J., Konig, T., Franke, D., Kuhnel, H.J., Henze, G., von, S.A., Moricke, A., Schrappe, M., Boos, J. & Lanvers-Kaminsky, C. (2011) Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E. coli asparaginase: a retrospective analysis within the ALL-BFM trials. Blood, 118, 5774-5782.
83. Woo, M.H., Hak, L.J., Storm, M.C., Sandlund, J.T., Ribeiro, R.C., Rivera, G.K., Rubnitz, J.E., Harrison, P.L., Wang, B., Evans, W.E., Pui, C.H. & Relling, M.V. (2000) Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 18, 1525-1532.
84. Wu, S.F., Chen, A.C., Peng, C.T. & Wu, K.H. (2008) Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia. Pediatric Blood and Cancer, 51, 824-825.
85. Wu, X.M., Ji, K.Q., Wang, H.Y., Li, G.F., Zang, B. & Chen, W.M. (2010) Total enteral nutrition in prevention of pancreatic necrotic infection in severe acute pancreatitis. Pancreas, 39, 248-251.
86. Yadav, D. & Pitchumoni, C.S. (2003) Issues in hyperlipidemic pancreatitis. Journal of Clinical Gastroenterology, 36, 54-62.
87. Yeung, C.Y., Lee, H.C., Huang, F.Y., Ho, M.Y., Kao, H.A., Liang, D.C., Hsu, C.H., Hung, H.Y., Chang, P.Y. & Sheu, J.C. (1996) Pancreatitis in children - experience with 43 cases. European Journal of Pediatrics, 155, 458-463.
88. Zaheer, A., Singh, V.K., Qureshi, R.O. & Fishman, E.K. (2012) The revised Atlanta classification for acute pancreatitis: updates in imaging terminology and guidelines. Abdominal Imaging, Epub ahead of print. doi: 10.1007/s00261-012-9908-0.
89. Zalewska-Szewczyk, B., Andrzejewski, W., Mlynarski, W., Jedrychowska-Danska, K., Witas, H. & Bodalski, J. (2007) The anti-asparagines antibodies correlate with l-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia. Leukemia and Lymphoma, 48, 931-936.
90. Zalewska-Szewczyk, B., Gach, A., Wyka, K., Bodalski, J. & Mlynarski, W. (2009) The cross-reactivity of anti-asparaginase antibodies against different l-asparaginase preparations. Clinical and Experimental Medicine, 9, 113-116.
91. Zavyalov, T., Khotsyna, Y. & Tenner, S. (2010) The role of antibiotics in the management of patients with acute necrotizing pancreatitis. Current Infectious Disease Reports, 12, 13-18.
92. Ziegler, D.W., Long, J.A., Philippart, A.I. & Klein, M.D. (1988) Pancreatitis in childhood. Experience with 49 patients. Annals of Surgery, 207, 257-261.